License and Technology Transfer Agreement with JMS Corporation
Patented IV Expres: Multimode Infusion Pump
(November 28, 2001)
Lausanne, Switzerland, November 28 , 2001 - Debiotech,
S.A., a privately held Swiss medical device company, reveals today
the name of its Japanese partner with whom it has entered into a
long term agreement for its IV ExpresTM infusion pump in Japan.
Under this Agreement, the leading Japanese company
JMS Corporation acquired exclusive rights to manufacture and market
an IV pump system and related disposable cassette from Debiotech,
which provide safe and cost-effective IV multi-mode therapy in both
alternate site and home care settings in Japan. The agreement is
based on upfront payment and royalties to Debiotech.
The IV ExpresTM Pump system developed by Debiotech,
together with its unique patented disposable cassette, provides
easy to use and accurate administration of intravenous fluids in
every condition of use. Its small size and light weight as well
as Telemedicine remote programming capability, with voice over data
telephone transmission, represents a significant improvement in
IV Therapy offering.
The IV ExpresTM Pump system is part of Debiotech's
advanced drug delivery systems designed to meet the growing market
need for improved administration systems, particularly in areas
such as the home care environment, alternate site, and for oncology,
patient analgesia or pediatric use.
JMS Corporation plans to market the IV ExpresTM
Pump system and its disposable cassette in Japan under its brand
name, using the already available manufacturing partners selected
Dr. Frédéric Neftel, CEO, Debiotech,
stated, "This Agreement is the result of a long term relationship
and we are today delighted to combine our efforts towards improving
the quality of life of patients in the field of IV therapy. This
collaboration will also create a strong market presence for one
of our leading products in Asia and contribute to our objective
of global success. JMS, who has built a strong reputation for the
quality of his products and enjoys a dominant market presence is,
with no doubt, in the best position to market and sell our IV ExpresTM
Pump system in Japan."
Dr. Hajime Kimura, President, JMS, stated, "We,
both parties have built a new cooperation throughout R&D, Manufacturing
and Marketing over IV therapeutic infusion devices after scrutinizing
every related facet of both parties with a charter of entrepreneurial
sprit and continuous improvement.The system effectively contributes
to the fundamentals of our infusion device technology which consists
of a product portfolio encompassing both intensive care and home
healthcare.This is also an unwavering step to reinforce our outstanding
IV device technology."
Debiotech S.A. specializes in the research and
development of innovative medical devices in the field of IV and
nutrition therapy, electronic infusion systems, drug reconstitution
and syringes, flow control, dialysis, diagnostics, implantable drug
delivery systems and micro-systems for insulin and peptide drug
ABOUT JMS Corporation
JMS Corporation was established in 1965 and is
Japan's second-largest producer of disposable medical supplies.
JMS Group employees over 2,000 in Asia, with 8 manufacturing plants
and over 350 sales representatives.
Head Office: 3-10-6 Hachobori, chuo-ku, Tokyo
President: Dr. Hajime Kimura
Web site: http://www.jms.cc
Paid-in Capital: 5.6 billions
of yen (End of March, 2001)
Consolidated Net Sales: 36 billions of yen (End of March, 2001)
Main Business: Manufacture and Sales of medical products, ex. I.V.
solution, blood bags, disposable medical devices, dialysis systems,
medical electronic products and home medical instruments, etc.